NCT03645850View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness

NAUnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

June 15, 2019

Conditions
Dry Eye
Interventions
DEVICE

Vismed gel Multi 0.3% eye drops

Ophthalmic use. Vismed gel Multi 0.3% eye drops. One to two drops instilled in each eye from 4 to 6 times per day during 84 days of treatment.

DEVICE

Vismed Multi 0.18% eye drops

Ophthalmic use. One to two drops instilled in each eye from 4 to 6 times per day during 84 days of treatment.

Sponsors

Lead Sponsor

Horus Pharma
All Listed Sponsors
lead

Horus Pharma

INDUSTRY